8-Apr-2025 Curbing harmful medicines: the promise of a unified African health products regulatory system University of the Witwatersrand Substandard and fake medicines remain a major threat in Africa, risking lives and fuelling drug resistance. A unified regulatory system, like the African Medicines Agency, backed by leadership training programmes like ARLP, could strengthen oversight, boost self-reliance, and save lives.
8-Apr-2025 Einstein research leads to designation of new type of diabetes Albert Einstein College of Medicine Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now officially recognized as a distinct form of the disease, known as type 5 diabetes. The new designation, made today by the International Diabetes Federation (IDF), stems largely from the research and advocacy of Meredith Hawkins, M.D., M.S., professor of medicine, the Harold and Muriel Block Chair in Medicine, and founding director of the Global Diabetes Institute at Albert Einstein College of Medicine.
8-Apr-2025 UC3M launches two new programs to create and consolidate spin-offs of its research personnel Universidad Carlos III de Madrid Universidad Carlos III de Madrid (UC3M) has launched two new business incubation and acceleration programmes, CR3A and CONSOLIDA, to promote the creation and consolidation of businesses that seek to offer products and services based on technologies and knowledge developed at the university.
8-Apr-2025 Eclipses, science, NASA firsts: Heliophysics big year highlights NASA/Goddard Space Flight Center From October 2023 to December 2024 — a period encompassing two solar eclipses across the U.S., two new NASA heliophysics missions, and one spacecraft’s history-making solar flyby — NASA celebrated the Sun’s widespread influence on our lives. Here are some of the highlights.
8-Apr-2025 PolyU interdisciplinary research harnesses mass spectrometry for groundbreaking solutions The Hong Kong Polytechnic University An interdisciplinary team led by Prof. Yao Zhongping, Associate Head and Professor of the Department of Applied Biology and Chemical Technology at The Hong Kong Polytechnic University, specialises in mass spectrometry (MS), analytical chemistry, chemical biology and multi-omics. The team develops and applies MS-based approaches to address fundamental and applied problems across various fields, including chemistry, biology, medicine, food science and information science.
8-Apr-2025 Two angels, a robot and 23: a Johns Hopkins Medicine organ transplant story Johns Hopkins Medicine A Johns Hopkins Medicine Organ Transplant Story
8-Apr-2025 AI does not threaten the world, but humans do University of the Arts Helsinki Claiming that machines are conscious and autonomous is not only misleading but also obscures human action, says postdoctoral researcher Dominik Schlienger from the University of the Arts Helsinki.
8-Apr-2025 An expert's take on why we should not fear AI University of Texas at Dallas Movies like “The Terminator,” in which an artificial intelligence system goes rogue and tries to wipe out humanity, depict our worst fears about AI. But outside of science fiction, there’s no need to be afraid of the technology becoming self-aware like the AI in the movies anytime soon, said Dr. Sriraam Natarajan, a professor of computer science in the Erik Jonsson School of Engineering and Computer Science at The University of Texas at Dallas. “I want to reassure everyone that AI-driven Armageddon is not happening,” Natarajan said. “‘The Terminator’ is a great movie. ‘The Matrix’ is great, but they are fiction and are not going to happen in reality.”
7-Apr-2025 From chess champion to quantum innovator, physicist is on top of her game University of Texas at Dallas At the age of 12, Dr. Bei Zeng was already the top chess player in her province in China and a prodigy in a family deeply rooted in the game. By the time she turned 17, after witnessing IBM’s Deep Blue supercomputer defeat the world’s best chess player, her world — and her future career — would shift. Today, Zeng is a professor of physics in the School of Natural Sciences and Mathematics at The University of Texas at Dallas, where she is at the forefront of quantum computing, quantum information science and artificial intelligence research.
7-Apr-2025 CMS decision on obesity medications leaves gap in health care access for millions of Americans The Obesity Society The Obesity Society is disappointed with the decision made by the Centers for Medicare and Medicaid Services (CMS) to continue its policy that restricts access to safe and effective obesity medications. The announcement that CMS will reject Part D coverage of obesity medications and application to the Medicaid program in a proposed rule last week has both clinical and ethical implications for those living with the chronic disease and the providers who treat them.
